US · Healthcare

Anavex Life Sciences Corp (AVXL)

Biotechnology

Anavex Life Sciences Corp (AVXL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AVXL

P/E ratio

18.00

Anavex Life Sciences Corp (AVXL) — FAQ

What is AVXL's P/E ratio?

The price-to-earnings (P/E) ratio for Anavex Life Sciences Corp (AVXL) is 18.00 (data as of 2026-03-23).

Does Anavex Life Sciences Corp pay a dividend?

Dividend yield is not available in the current snapshot for Anavex Life Sciences Corp (AVXL). Check the MyAverix Finance app for the latest dividend data.

What sector is Anavex Life Sciences Corp in?

Anavex Life Sciences Corp (AVXL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AVXL listed on?

AVXL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)